Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...
| Main Authors: | , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
MDPI AG
2023-05-01
|
| סדרה: | Pharmaceuticals |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1424-8247/16/6/802 |